{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,461.00",
    "chg": 39,
    "chgp": "2.74%",
    "dir": 1,
    "prev_price": "1,422.00",
    "mcapval": "6,728.43 Cr",
    "mcap": "Small Cap",
    "scripcode": 544319,
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0RB801010",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "4.52 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-valuation-shifts-amid-strong-market-performance-3997953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SenoresPharmace_valuationdot_3997953.png",
        "date": "2026-05-19 08:03:11",
        "description": "Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive classification, despite robust stock price gains and strong operational metrics. This article analyses the evolving price attractiveness of the small-cap pharmaceutical player in the context of its peer group and historical benchmarks."
      }
    ],
    "total": 15,
    "sid": "10039497",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "04-Aug-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "04-Aug-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinzer Report dated August 04 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Aug-2026",
      "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Monday July 27 2026 for Q1FY27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharmaceuticals Ltd Valuation Shifts Amid Strong Market Performance

2026-05-19 08:03:11

Senores Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive classification, despite robust stock price gains and strong operational metrics. This article analyses the evolving price attractiveness of the small-cap pharmaceutical player in the context of its peer group and historical benchmarks.

Read More

View All News